These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2209041)

  • 1. Role of prostaglandin E1 in reducing pulmonary vascular resistance in an experimental model of acute lung injury.
    Dervin G; Calvin JE
    Crit Care Med; 1990 Oct; 18(10):1129-33. PubMed ID: 2209041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
    Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
    Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vascular pressure-flow characteristics. Effects of dopamine before and after pulmonary embolism.
    Ducas J; Stitz M; Gu S; Schick U; Prewitt RM
    Am Rev Respir Dis; 1992 Aug; 146(2):307-12. PubMed ID: 1489117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PGE1 in experimental vasoconstrictive pulmonary hypertension.
    Dagher E; Dumont L; Chartrand C; Blaise G
    Eur Surg Res; 1993; 25(2):65-73. PubMed ID: 8482311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
    Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
    Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC; McLean R; Rosenthal MH; Pearl RG
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome.
    Kunimoto F; Arai K; Isa Y; Koyano T; Kadoi Y; Saito S; Goto F
    Anesth Analg; 1997 Sep; 85(3):507-13. PubMed ID: 9296401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension.
    Heerdt PM; Weiss CI
    Ann Thorac Surg; 1990 Mar; 49(3):463-5. PubMed ID: 2106846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
    Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypoxia on the hemodynamic actions of prostaglandin E1.
    Alpert JS; Beller GA; Giamber SR; Saltz SB
    Prostaglandins; 1976 May; 11(5):783-97. PubMed ID: 935511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
    Priebe HJ
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1232-9. PubMed ID: 3142278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of right atrial infusion of PGE1 in sepsis-induced pulmonary hypertension.
    Marini CP; Woloszyn T; Coons M; Tachmes L; Nathan I; Cunningham JN; Jacobowitz IJ
    J Surg Res; 1990 Dec; 49(6):476-82. PubMed ID: 2124641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator therapy for right ventricular failure.
    Sakaguchi K; Tanaka N; Sawada M; Araki Y; Fujita K
    Jpn Circ J; 1984 Apr; 48(4):357-64. PubMed ID: 6538914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pulmonary hypertension and hypoxia due to oleic acid induced lung injury with intratracheal prostaglandin E1 during partial liquid ventilation.
    Nakazawa K; Uchida T; Matsuzawa Y; Yokoyama K; Makita K; Amaha K
    Anesthesiology; 1998 Sep; 89(3):686-92. PubMed ID: 9743406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.
    Ducas J; Girling L; Schick U; Prewitt RM
    Circulation; 1986 May; 73(5):1050-7. PubMed ID: 3698227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure.
    Popat KD; Pitt B
    Am Heart J; 1982 Apr; 103(4 Pt 1):485-9. PubMed ID: 7199815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of prostaglandin E1 on the systemic and regional hemodynamics of dogs].
    Ismailov ShI; Flerov EV
    Kardiologiia; 1977 Jul; 17(7):122-6. PubMed ID: 926541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
    Naeije R; Mélot C; Mols P; Hallemans R
    Am Rev Respir Dis; 1982 Jan; 125(1):1-5. PubMed ID: 6802045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vascular pressure-flow plots in canine oleic acid pulmonary edema. Effects of prostaglandin E1 and nitroprusside.
    Leeman M; Lejeune P; Mélot C; Naeije R
    Am Rev Respir Dis; 1988 Aug; 138(2):362-7. PubMed ID: 3143286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.